Singapore's RIE2030 is not a research plan. Yet many people encountering RIE2030 for the first time ask: "So how much research funding will be spent where?"
This is a question many people ask the moment they see the RIE 2030 document. The name itself stands for Research, Innovation and Enterprise. However, it is precisely from this question that the most common misreading of RIE2030 begins. The moment you read RIE2030 as a research plan, the core of this document disappears.
RIE2030 is not simply a research plan. It is an economic strategy.
The difference between a research plan and an economic strategy is simple. A research plan asks what will be researched, while an economic strategy asks what structure that research will create. RIE2030 is much closer to the latter than the former.
What the Singapore government repeatedly emphasizes in RIE2030 is not "how much will be invested." Rather, the question that appears more frequently is this: How does research and innovation lead to industry, industry to society, and those outcomes back to national assets?
This document contains almost no technology roadmaps in the traditional sense. Instead, there is structure. The domains of manufacturing, health, urban, and digital are not research fields but stages for policy experimentation. Each domain is designed not for technology development itself, but as a mechanism to verify how technology operates and its connection structures.
Take the manufacturing domain, for example. RIE2030 does not treat manufacturing as "a problem of making factories more efficient." It asks how data, processes, energy, resources, and supply chains combine to create new value structures. This is not a research topic but a question about economic structure.
The same applies to health. Rather than technology to cure diseases, the focus is on how prevention and data-driven management change social cost structures. This is not a matter of medical technology but of national finance and welfare structure.
Viewed this way, RIE2030 is not a document dealing with R&D, but one that defines how R&D outcomes should be utilized. Research is the means; structural transformation is the purpose.
This is why the Singapore government publicly released this document. It was not created for researchers alone to see, but because industry, the financial sector, and policymakers all need to read it from the same perspective. It is an attempt to first share what structure they want to create, rather than where to invest.
Here, I would like to add one thing.
Singapore is not saying it will increase research, but that it will change the position of research. This difference is decisive.
Many countries view research as fuel for growth. They expect that more investment will produce better technology, and that technology will lead to industry. However, developed technology does not automatically become industry. If the structure for technology to operate is not prepared, outcomes remain as reports.
RIE2030 changes precisely that premise. Before creating technology, it designs the order in which technology will operate.
At this point, I am reminded of the concept of transformational economy.
Transformational economy is an economic model that asks not what to produce more of, but what to convert into different value. Even with the same resources and same technology, entirely different values are created depending on what structure they are placed within.
Consider ESG, for example. For many companies, ESG is regulatory compliance and a cost item. However, the moment ESG is digitized within a Digital ESG structure and connected to investment decision criteria, ESG becomes not an obligation but a trust asset. Trust lowers capital procurement costs and enables global partnerships. The same ESG can become either a cost or an asset depending on the structure. This is transformation.
The same applies to manufacturing. Process data can become the foundation for new industry standards rather than mere operational records, and energy efficiency improvements can be connected to carbon finance. The essence of manufacturing does not change; the position of manufacturing changes. It moves from being a production space to a platform for accumulating assets.
Health also does not stop at treatment technology. Prevention data and precision medicine platforms change national fiscal structures. It is not a matter of reducing medical costs, but of creating a foundation to maintain productivity even amid population aging.
Viewed this way, RIE2030 is not a document about increasing research, but about designing an economic structure that operates through research.
And that choice is not a matter of research policy but of growth strategy.
RIE2030 does not explain outcomes in terms of short-term growth rates. Instead, it uses the language of national assets. Data becomes an asset, standards become assets, and trust becomes an asset. Research outcomes are treated not as costs to be consumed but as assets to be accumulated.
At this point, we are led to ask again: What do our research policy documents place at their center? The quantity of research, or the structure that research creates?
RIE2030 chose the latter.
In the next installment, I will examine why Singapore judged that existing growth models, particularly the circular economy alone, were insufficient. This is because the questions posed by RIE2030 actually begin from that point.
·Chief Industry Officer reporting directly to the President of Nanyang Technological University (NTU), Director of the Centre for Cross Economy, Flagship Programme Director
*He researches national growth strategies and transformational economy models based on science, technology, and digital. He proposes transformational economic structures combining RIE2030, Digital Economy, and Digital ESG, and participates in international policy validation and standard design centered on Singapore and ASEAN. Through transformative research connecting research, industry, and policy, he continues discussions on the next-generation global growth order.